New York, New Jersey
Licensing and Technology Transfer
Blockchain Technology & Digital Currency
Vanderbilt University Law School (JD)
Delaware University (MS)
University of Science and Technology of China (BS)
Wei advises clients on the management of global IP portfolios, including the freedom to operate, invalidity and non-infringement issues, as well as on various regulatory compliance matters. Some of the clients he has represented include Celgene Corp., Genentech, Inc., Boston Scientific Corp., and Purdue Pharma L.P.
Wei also performs due diligence investigations in an acquisition, licensing, and technology transfer transactions, and drafts and negotiates commercial agreements. He represented a number of U.S. pharmaceutical companies in acquisitions of both privately held and publicly traded companies. He is also experienced in advising start-ups and investment funds in cross-border licensing and financing transactions.
In addition, Wei has represented both U.S. and foreign clients in IP infringement actions and commercial disputes. Some representative matters include advising U.S. companies in invalidation and opposition proceedings in various countries and defending foreign corporations in patent infringement cases in the U.S.
Prior to joining the firm, Wei worked at the New York office of a major international law firm. He was selected to the list of New York-Metro rising stars for intellectual property law by Super Lawyers in years 2014-2017.
A Different View of the U.S. Broadcom Decision, EETimes, March 2018.